Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion type Assertion NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_head.
- NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion description "[As an example, we predicted that RAD50 with TRF2 have prostate cancer specific interaction that turned out to be having validation from the literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_provenance.
- NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion evidence source_evidence_literature NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_provenance.
- NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion SIO_000772 21777411 NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_provenance.
- NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion wasDerivedFrom befree-2016 NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_provenance.
- NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_assertion wasGeneratedBy ECO_0000203 NP911270.RADs4E9ZiMXX5mAI6h0_YX9N4lZ-3icm83WBaeDBZlnTQ130_provenance.